Chronic obstructive pulmonary disease phenotypes past, present, and future

Annals of the American Thoracic Society

Volumn 12, Issue 3, 2015, Pages 289-290

  Burgel, Pierre Régis ^a,b   Sethi, Sanjay ^c,d   Kim, Victor ^e  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITY AT BUFFALO   (United States)

^d VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

^e TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DISEASE EXACERBATION; DYSPNEA; EDITORIAL; EMPHYSEMA; EXERCISE; HEALTH STATUS; HUMAN; PHENOTYPE; PROGNOSIS; SMOKING;

EID: 84964194125     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201501-011ED     Document Type: Editorial

References (8)

1. Petty TL. The history of COPD. Int J Chron Obstruct Pulmon Dis 2006;1:3-14.
2. Dornhorst AC. Respiratory insufficiency. Lancet 1955;268:1185-1187.
3. Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, MacNee W, Miller BE, Rennard S, Silverman EK, et al.; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010;11:122.
4. Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, Fabbri LM, Goldin JG, Jones PW, Macnee W, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 2010;182:598-604.
5. Burgel PR, Paillasseur JL, Caillaud D, Tillie-Leblond I, Chanez P, Escamilla R, Court-Fortune I, Perez T, Carré P, Roche N; Initiatives BPCO Scientific Committee. Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. Eur Respir J 2010;36:531-539.
6. Burgel PR, Paillasseur JL, Roche N. Identification of clinical phenotypes using cluster analyses in COPD patients with multiple comorbidities. Biomed Res Int 2014;2014:420134.
7. Rennard S, Locantore N, Delafont B, Tal-Singer R, Silverman E, Vestbo J, Miller B, Bakke P, Celli B, Calverley P, et al. Identification of five COPD subgroups with different prognoses in the ECLIPSE cohort using cluster analysis. Ann Am Thorac Soc 2015;12:303-312.
8. Agusti A. The path to personalised medicine in COPD. Thorax 2014;69:857-864.